Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|2926-2932

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 2926-2932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant temozolomide improves long-term survival in glioblastoma

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Clinical Impact of Adjuvant Chemotherapy in Glioblastoma Multiforme: A Meta-Analysis

By Spiegel Brennan M.R.   Esrailian Eric   Laine Loren  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 775-787

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme

By Martikainen Janne A.  

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 803-815

Adis International

Access to resources Recommend Favorite

Survival of Patients with Recurrent Malignant Glioma Treated with Temozolomide: A Retrospective Observational Study

By Trippoli S.   Pelagotti F.   Messori A.   Vacca F.   Vaiani M.   Maltoni S.  

Drugs in R&D, Vol. 4, Iss. 5, 2003-01 ,pp. : 285-291

Adis International

Access to resources Recommend Favorite

Treatment with a brain cancer vaccine followed by antineoplastic chemotherapy results in synergistic clinical effects in patients with de novo glioblastoma multiforme

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite